Zobrazeno 91 - 100
of 209
pro vyhledávání: '"Marjolein van Ballegooijen"'
Autor:
Corine Penning, Steffie K. Naber, Kirsten Rozemeijer, Jan A. C. Hontelez, Suzette M. Matthijsse, Marjolein van Ballegooijen, Sake J. de Vlas, Joost van Rosmalen, Inge M.C.M. de Kok, Roel Bakker
Publikováno v:
Vaccine, 33, 5357-64
Vaccine, 33(41), 5357-5364. Elsevier
Vaccine, 33, 41, pp. 5357-64
Vaccine, 33(41), 5357-5364. Elsevier
Vaccine, 33, 41, pp. 5357-64
Background: Mathematical modelling is used to estimate the effectiveness of HPV vaccination. These estimates depend strongly on herd immunity and thus on naturally acquired immunity, a mechanism of which little is known. We estimated the impact of di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a76abc05033410859efb7590c1e8c54
http://hdl.handle.net/2066/152832
http://hdl.handle.net/2066/152832
Autor:
Joel H. Rubenstein, Harry J. de Koning, Iris Lansdorp-Vogelaar, John M. Inadomi, Sonja Kroep, Reinier G.S. Meester, Marjolein van Ballegooijen
Publikováno v:
Gastroenterology, 149(3), 577-+. W.B. Saunders
This article has an accompanying continuing medical education activity on page e14. Learning Objective: Upon completion of this activity, successful learners will be able to (a) identify factors that may account for differences in rates of Barrett’
Autor:
Jacqueline C. Reijerink, Aafke H.C. van Roon, Monique E. van Leerdam, Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen, Lieke Hol, Anneke J. van Vuuren, Atija Kapidzic, Miriam P. van der Meulen, Caspar W. N. Looman, Ernst J. Kuipers
Publikováno v:
Clinical Gastroenterology and Hepatology, 13(8), 1464-+. W.B. Saunders
BACKGROUND & AIMS: Fecal immunochemical tests (FITs) are used widely in colorectal cancer screening. Programs use the same fecal hemoglobin threshold for colonoscopy referral for men and women, but it is unclear whether FIT performs equally in both s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c5bbd01a5aa888fad523137c6182f08
https://pure.eur.nl/en/publications/85461b4e-dc34-4d18-9e70-cf55d259a233
https://pure.eur.nl/en/publications/85461b4e-dc34-4d18-9e70-cf55d259a233
Publikováno v:
International Journal of Cancer. 120:806-812
The success of screening, an important cancer prevention tool, depends on the quality and efficiency of protocols and guidelines for screening and follow-up. However, even centrally organized screening programs such as the Dutch cervical screening pr
Autor:
J. Dik F. Habbema, Marjolein van Ballegooijen, Sidney J. Winawer, Rob J. de Boer, Iris Lansdorp – Vogelaar, Ann G. Zauber, Deborah Schrag
Publikováno v:
Cancer, 107, 1624-1633. John Wiley & Sons Inc.
BACKGROUND. Although colorectal cancer (CRC) is the second leading cause of cancer death in the U.S., available interventions to reduce CRC mortality are disseminated only partially throughout the population. This study assessed the potential reducti
Autor:
Anneke J van Vuuren, Aafke H. van Roon, Iris Lansdorp-Vogelaar, Lieke Hol, Ernst J. Kuipers, Kirsten Izelaar, Atija Kapidzic, Monique E. van Leerdam, Wolfert Spijker, Marjolein van Ballegooijen
Publikováno v:
Gut, 66(1), 118-123. BMJ Publishing Group
Objective Limited data exist on attendance and additional yield of 2-sample faecal immunochemical testing (FIT) screening during multiple rounds. We therefore conducted a population-based colorectal cancer screening trial comparing attendance and yie
Autor:
Kirsten Rozemeijer, Suzette M. Matthijsse, Inge M.C.M. de Kok, Folkert J. van Kemenade, Corine Penning, Joost van Rosmalen, Steffie K. Naber, Marjolein van Ballegooijen
Publikováno v:
Journal of Medical Screening, 22(3), 144-150. SAGE Publications Ltd
Objective Over the last decade, cervical intraepithelial neoplasia (CIN) detection has increased in the Netherlands. We investigated the underlying mechanism by quantifying the increase, and analyzing patterns of CIN and cervical cancer detection ove
Autor:
Matejka Rebolj, Chris J.L.M. Meijer, Peter J.F. Snijders, Feja J. Voorhorst, René H.M. Verheijen, Frits A. de Schipper, Marjolein van Ballegooijen, Aagje G. Bais, Theo J.M. Helmerhorst, Dries A.J. van der Meulen
Publikováno v:
International Journal of Cancer, 116(1), 122-129. Wiley-Liss Inc.
Bais, AG, Rebolj, M, Snijders, P J F, de Schipper, FA, van der Meulen, D A, Verheijen, R H, Voorhorst, F J, van Ballegooijen, M, Meijer, C J L M & Helmerhorst, TJ 2005, ' Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines ', International Journal of Cancer, vol. 116, no. 1, pp. 122-129 . https://doi.org/10.1002/ijc.20958
Bais, AG, Rebolj, M, Snijders, P J F, de Schipper, FA, van der Meulen, D A, Verheijen, R H, Voorhorst, F J, van Ballegooijen, M, Meijer, C J L M & Helmerhorst, TJ 2005, ' Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines ', International Journal of Cancer, vol. 116, no. 1, pp. 122-129 . https://doi.org/10.1002/ijc.20958
In the Netherlands 2% of cervical smears in the cervical cancer screening program are read as borderline or mildly dyskaryotic cytology (BMD smear). Only in about 10% of these women a high-grade CIN lesion (CIN II-III) is present; therefore referral
Autor:
Hans J.F. Keuning, Mathilde E. Boon, Marjolein van Ballegooijen, Krijn van Groningen, Feja J. Voorhorst, Gladys R.J. Zandwijken, Lawrence Rozendaal, Adriaan J. C. van den Brule, Folkert J. van Kemenade, Chris J.L.M. Meijer, Peter J.F. Snijders, René H.M. Verheijen, A Joan P Boeke, Nicole W.J. Bulkmans
Publikováno v:
International Journal of Cancer, 110(1), 94-101. Wiley-Liss Inc.
Bulkmans, N W J, Rozendaal, L, Snijders, P J F, Voorhorst, F J, Boeke, AJ, Zandwijken, GR, van Kemenade, F J, Verheijen, R H M, v Groningen, K, Boon, ME, Keuning, HJ & van Ballegooijen, M 2004, ' POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. ', International Journal of Cancer, vol. 110, no. 1, pp. 94-101 . https://doi.org/10.1002/ijc.20076
Bulkmans, N W J, Rozendaal, L, Snijders, P J F, Voorhorst, F J, Boeke, AJ, Zandwijken, GR, van Kemenade, F J, Verheijen, R H M, v Groningen, K, Boon, ME, Keuning, HJ & van Ballegooijen, M 2004, ' POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. ', International Journal of Cancer, vol. 110, no. 1, pp. 94-101 . https://doi.org/10.1002/ijc.20076
Cytological cervical screening is rather inefficient because of relatively high proportions of false negative and false positive smears. To evaluate the efficiency of high-risk human papillomavirus (hrHPV) testing, by GP5+/6+ PCR-enzyme immunoassay (
Autor:
J. Dik F. Habbema, Marjolein van Ballegooijen, Wim Quint, Matthé P.M. Burger, M. Elske van den Akker-van Marle, Willem Jan Meerding
Publikováno v:
Journal of Clinical Epidemiology. 55:1025-1032
The objective of this article was to evaluate the utility of high-risk human papillomavirus (HR-HPV) testing for triage of women referred for colposcopy because of abnormal smears. We considered women with persistent mild or moderate dyskaryosis and